Risk factors for bisphosphonate-associated osteonecrosis of the jaw in the prospective randomized trial of adjuvant bisphosphonates for early-stage breast cancer (SWOG 0307)

PURPOSE: Bisphosphonates reduce bone metastases in postmenopausal women with early-stage breast cancer but carry the risk of bisphosphonate-related osteonecrosis of the jaw (BRONJ). We describe risk factors for BRONJ and compare BRONJ provoked by infection or trauma with spontaneous lesions, which c...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Support Care Cancer
Autors principals: Kizub, Darya, Miao, Jieling, Schubert, Mark M., Paterson, Alexander H.G., Clemons, Mark, Dees, Elizabeth C., Ingle, James N., Falkson, Carla I., Barlow, William E., Hortobagyi, Gabriel N., Gralow, Julie R.
Format: Artigo
Idioma:Inglês
Publicat: 2020
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7956914/
https://ncbi.nlm.nih.gov/pubmed/32929540
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00520-020-05748-8
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars